What is the shared primary mechanism of action for ACE inhibitors and ARBs in blood pressure management?

Study for the WGU NURS6800 D116 Advanced Pharmacology Exam. Use flashcards and multiple-choice questions with hints and explanations. Prepare thoroughly for your exam!

Multiple Choice

What is the shared primary mechanism of action for ACE inhibitors and ARBs in blood pressure management?

Explanation:
Both ACE inhibitors and ARBs lower blood pressure by interrupting the renin-angiotensin-aldosterone system. ACE inhibitors block the conversion of angiotensin I to angiotensin II, reducing angiotensin II–mediated vasoconstriction and aldosterone release. ARBs block the angiotensin II type 1 receptor, preventing angiotensin II from producing its usual effects. Either way, there is less vasoconstriction and less aldosterone-driven sodium and water retention, leading to lower blood pressure. The other options involve different drug classes—statins affect cholesterol synthesis, beta-blockers blunt sympathetic stimulation, and PPAR gamma activators are used for insulin sensitivity—so they don’t share the same primary mechanism as ACE inhibitors and ARBs.

Both ACE inhibitors and ARBs lower blood pressure by interrupting the renin-angiotensin-aldosterone system. ACE inhibitors block the conversion of angiotensin I to angiotensin II, reducing angiotensin II–mediated vasoconstriction and aldosterone release. ARBs block the angiotensin II type 1 receptor, preventing angiotensin II from producing its usual effects. Either way, there is less vasoconstriction and less aldosterone-driven sodium and water retention, leading to lower blood pressure. The other options involve different drug classes—statins affect cholesterol synthesis, beta-blockers blunt sympathetic stimulation, and PPAR gamma activators are used for insulin sensitivity—so they don’t share the same primary mechanism as ACE inhibitors and ARBs.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy